Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration – a retrospective study-Reference-Cited by-同舟云学术

Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration – a retrospective study

Published:2017-12-18 Issue:8 Volume:59 Page:1871-1877
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lamar Zanetta S.¹²^ORCID,Dothard Andrew¹,Kennedy LeAnne³,Isom Scott¹⁴,Robinson Mac²,Vaidya Rakhee¹²,Hurd David¹²,McClain Donald⁵,Lesser Glenn¹²

Affiliation:

1. Department of Internal Medicine – Section of Hematology and Oncology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA;

2. Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA;

3. Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA;

4. Department of Biostatistical Sciences, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA;

5. Department of Internal Medicine – Section of Endocrinology and Metabolism, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA

Funder

Wake Forest Research Base

Wake Forest Baptist Comprehensive Cancer Center’s NCI Cancer Center

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1410889

Reference26 articles.

1. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

2. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

3. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

4. The Prednisone Dosage in the CHOP Chemotherapy Regimen for Non-Hodgkin's Lymphomas (NHL): Is There a Standard?

5. Hyperglycemia During Chemotherapy for Hematologic and Solid Tumors Is Correlated With Increased Toxicity

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Important aspects of carbohydrate metabolism disorders development in hematology/oncology patients during therapy with glucocorticosteroids: a review of the literature;Oncohematology;2024-04-02

2. Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma;Current Oncology;2023-11-28

3. Effect of steroid treatment on the diagnostic yield of baseline 18f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma;EJNMMI Research;2022-09-14

4. Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy;Blood Advances;2022-08-01

5. Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-07